JP2022538475A5 - - Google Patents
Info
- Publication number
- JP2022538475A5 JP2022538475A5 JP2021578186A JP2021578186A JP2022538475A5 JP 2022538475 A5 JP2022538475 A5 JP 2022538475A5 JP 2021578186 A JP2021578186 A JP 2021578186A JP 2021578186 A JP2021578186 A JP 2021578186A JP 2022538475 A5 JP2022538475 A5 JP 2022538475A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding protein
- seq
- group
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025072533A JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962870232P | 2019-07-03 | 2019-07-03 | |
| US62/870,232 | 2019-07-03 | ||
| US202063020177P | 2020-05-05 | 2020-05-05 | |
| US63/020,177 | 2020-05-05 | ||
| US202063021826P | 2020-05-08 | 2020-05-08 | |
| US63/021,826 | 2020-05-08 | ||
| PCT/US2020/040642 WO2021003357A1 (en) | 2019-07-03 | 2020-07-02 | Anti-new york esophageal squamous cell carcinoma 1 (ny-eso-1) antigen-binding proteins and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072533A Division JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538475A JP2022538475A (ja) | 2022-09-02 |
| JP2022538475A5 true JP2022538475A5 (enExample) | 2023-07-10 |
| JP7674278B2 JP7674278B2 (ja) | 2025-05-09 |
Family
ID=74101175
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021578186A Active JP7674278B2 (ja) | 2019-07-03 | 2020-07-02 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
| JP2025072533A Pending JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072533A Pending JP2025156298A (ja) | 2019-07-03 | 2025-04-24 | 抗ニューヨーク食道扁平上皮がん１（ｎｙ－ｅｓｏ－１）抗原結合タンパク質およびその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12600783B2 (enExample) |
| EP (1) | EP3993817A4 (enExample) |
| JP (2) | JP7674278B2 (enExample) |
| KR (1) | KR20220042137A (enExample) |
| CN (2) | CN120248123A (enExample) |
| AU (1) | AU2020301027B2 (enExample) |
| BR (1) | BR112021026831A2 (enExample) |
| CA (1) | CA3145857A1 (enExample) |
| CL (1) | CL2021003550A1 (enExample) |
| CO (1) | CO2022000804A2 (enExample) |
| IL (1) | IL289573A (enExample) |
| MA (1) | MA56468A (enExample) |
| MX (1) | MX2022000081A (enExample) |
| PH (1) | PH12021553306A1 (enExample) |
| WO (1) | WO2021003357A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3175577A1 (en) | 2020-03-30 | 2021-10-07 | Mie University | Bispecific antibody |
| WO2023176881A1 (ja) * | 2022-03-16 | 2023-09-21 | 第一三共株式会社 | 多重特異的分子と免疫チェックポイント阻害剤の組み合わせ |
| CN116970614A (zh) * | 2022-12-29 | 2023-10-31 | 达冕疫苗(广州)有限公司 | 编码ny-eso-1的核糖核酸疫苗的组合物和方法 |
| IL322890A (en) | 2023-02-28 | 2025-10-01 | Regeneron Pharma | Multispecific molecules containing an MHC-peptide complex containing an MHC domain and an antigenic peptide and a partially targeted immune cell antigen |
| CN117843794B (zh) * | 2023-12-01 | 2026-07-31 | 浙江大学 | 一种抗ny-eso-1的纳米抗体及其应用 |
| WO2026006794A1 (en) * | 2024-06-27 | 2026-01-02 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric antigen receptors and uses thereof |
| CN119161418B (zh) * | 2024-08-30 | 2025-11-21 | 天津大学 | 一种结合ny-eso-1抗原的蛋白 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061623A (zh) * | 1990-06-01 | 1992-06-03 | 里珍纳龙药品有限公司 | 睫状神经营养性因子受体 |
| WO2003068800A2 (en) * | 2002-02-13 | 2003-08-21 | Ludwig Institute For Cancer Research | Isolated peptides which bind to hla molecules and uses thereof |
| US8193318B2 (en) * | 2002-08-14 | 2012-06-05 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
| WO2005113595A2 (en) * | 2004-05-19 | 2005-12-01 | Avidex Ltd | High affinity ny-eso t cell receptor |
| PL2457928T3 (pl) | 2007-03-13 | 2017-10-31 | Univ Zuerich | Monoklonalne ludzkie przeciwciało swoiste względem nowotworu |
| WO2010106431A2 (en) | 2009-03-20 | 2010-09-23 | Ludwig Institute For Cancer Research Ltd | High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof |
| WO2010141986A1 (en) * | 2009-06-09 | 2010-12-16 | Mabdesign Pty Ltd | Novel antibodies and uses therefor |
| DK2971045T3 (da) * | 2013-03-13 | 2019-09-16 | Health Research Inc | Sammensætninger og fremgangsmåder til anvendelse af rekombinante T-celle-receptorer til direkte genkendelse af tumorantigen |
| CN104450615B (zh) * | 2013-09-25 | 2020-12-15 | 深圳市北科生物科技有限公司 | 一种具有双特异性抗体的细胞CTL(BiAT)及其制备方法与应用 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| US20160081314A1 (en) * | 2014-09-19 | 2016-03-24 | Regeneron Pharmaceuticals, Inc. | Chimeric Antigen Receptors |
| IL281396B (en) | 2015-06-09 | 2022-07-01 | Memorial Sloan Kettering Cancer Center | T cell receptor-like antibody agents specific for ebv latent membrane protein 2a peptide presented by human hla |
| RU2018102526A (ru) | 2015-06-24 | 2019-07-25 | Еурека Терапьютикс, Инк. | Конструкции, направленные на комплексы пептида ny-eso-1/мнс, и их применение |
| CN106729698A (zh) * | 2015-11-25 | 2017-05-31 | 宁波美丽人生医药生物科技发展有限公司 | NY-ESO-1有作为增强Art v1(wtArt)过敏原免疫反应分子佐剂的作用 |
| US9994098B2 (en) | 2015-12-23 | 2018-06-12 | Xiaolin Ai | Multimode electromechanical variable speed transmission apparatus with smooth mode shifting and method of controlling the same |
| JP2018013957A (ja) * | 2016-07-21 | 2018-01-25 | 東芝テック株式会社 | 読取装置、サーバ装置、及びプログラム |
| AU2018207172B2 (en) * | 2017-01-13 | 2023-10-12 | Mink Therapeutics, Inc. | T cell receptors that bind to NY-ESO-1 and methods of use thereof |
| CN110891977B (zh) * | 2017-05-11 | 2023-10-27 | 温口特 | 特异性结合mrs的单克隆抗体 |
| IL299348B2 (en) * | 2017-06-28 | 2025-05-01 | Regeneron Pharma | Antigen-binding proteins against human papillomavirus and methods of using them |
| WO2019084538A1 (en) | 2017-10-27 | 2019-05-02 | Board Of Regents, The University Of Texas System | TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF |
| CN108383908A (zh) * | 2018-02-05 | 2018-08-10 | 昆山百尔泰生物科技有限公司 | 识别人源ctla-4并阻断其功能的全人源单克隆抗体或抗体片段及其制备方法和用途 |
| BR112022001194A2 (pt) | 2019-07-24 | 2022-06-07 | Regeneron Pharma | Receptores de antígeno quimérico com especificidade de mage a4 e usos dos mesmos |
| CA3175577A1 (en) * | 2020-03-30 | 2021-10-07 | Mie University | Bispecific antibody |
| WO2021226063A1 (en) * | 2020-05-05 | 2021-11-11 | Regeneron Pharmaceuticals, Inc. | Car comprising cd28 zeta and cd3 zeta |
-
2020
- 2020-07-02 JP JP2021578186A patent/JP7674278B2/ja active Active
- 2020-07-02 CA CA3145857A patent/CA3145857A1/en active Pending
- 2020-07-02 KR KR1020227003658A patent/KR20220042137A/ko active Pending
- 2020-07-02 CN CN202510427533.6A patent/CN120248123A/zh active Pending
- 2020-07-02 EP EP20835029.8A patent/EP3993817A4/en active Pending
- 2020-07-02 CN CN202080061474.0A patent/CN114302733B/zh active Active
- 2020-07-02 US US17/622,307 patent/US12600783B2/en active Active
- 2020-07-02 MA MA056468A patent/MA56468A/fr unknown
- 2020-07-02 BR BR112021026831A patent/BR112021026831A2/pt unknown
- 2020-07-02 WO PCT/US2020/040642 patent/WO2021003357A1/en not_active Ceased
- 2020-07-02 AU AU2020301027A patent/AU2020301027B2/en active Active
- 2020-07-02 PH PH1/2021/553306A patent/PH12021553306A1/en unknown
- 2020-07-02 MX MX2022000081A patent/MX2022000081A/es unknown
-
2021
- 2021-12-29 CL CL2021003550A patent/CL2021003550A1/es unknown
-
2022
- 2022-01-02 IL IL289573A patent/IL289573A/en unknown
- 2022-01-28 CO CONC2022/0000804A patent/CO2022000804A2/es unknown
-
2025
- 2025-04-24 JP JP2025072533A patent/JP2025156298A/ja active Pending